Becoming a “Westernized” country is often linked with obesity and the chronic health conditions associated with it, including diabetes, heart disease, and cancer. The importance of increased calorie intake and decreased energy usage hasn’t really been evaluated.

Glucagon-like peptide medications (AKA GLP-1 agonists) such as Wegovy and Zepbound are taking the weight loss industry to a whole new level.

According to a recent Gallop poll, nearly 15.5 million US adults have used weight loss medications. 1 The CDC National Center for Health Statistics notes that over 1 in 4 adults with diabetes have used injectable medications as well. 2